Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities

Go back to Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities
Meridian Bioscience, Inc. (NASDAQ: VIVO) Delayed: 2.42 +0.14 (6.14%)
Previous Close $2.28    52 Week High $21.49 
Open $2.24    52 Week Low $15.75 
Day High $2.44    P/E 2.75 
Day Low $2.20    EPS $0.88 
Volume 562,605